Assisted reproductive technology has advanced significantly since the first healthy IVF baby was born more than 35 years ago.
But debate continues about whether identified risks are attributable to assisted reproductive technology (Art) or to parental characteristics affecting embryo quality and fertility. Further, a few publications are reporting on the incidence of genetic abnormalities and congenital malformation in Art children as against naturally conceived children.
A few years ago, collaborative research from the Liggins Institute and Fertility Associates gained attention when it was found IVF children were a bit taller than expected and had more favourable lipid or cholesterol profiles. This was reassuring, considering the hypothesis that their lower birth weight might be associated with poorer health long term.
Since then, a variety of studies have been done, some showing minor inherited changes but none raising significant concerns.
Fertility Associates and the Liggins Institute have followed up two other groups of children born after assisted reproduction - children from frozen-thawed embryos and children born after their mothers used Clomiphene (an ovulation induction medication). Those conceived from frozen embryos were the closest to children conceived naturally in height and metabolic measurements such as blood lipids. Children conceived after Clomiphene were a little shorter. The differences in height and blood lipids are too small to be of practical concern but the differences may provide clues.